Home Cullinan Therapeutics

Cullinan Therapeutics

In operation
Post-IPO Round
Antitumor Drug Developer
Basic
Enterprise Profile

Basic Information

Cullinan Oncology is a developer of external cancer treatment drugs, and if early studies show that a drug is not working, the drug program will be quickly terminated. The company's therapeutic drugs are developed through assets obtained either via internal laboratories or externally through commercial, academic, and pharmaceutical collaborations, enabling researchers to access a highly diversified portfolio of oncology therapeutics with a unique and cost-effective business model.
Cullinan Therapeutics, Inc.
Cambridge,Massachusetts,United States of America
15~50 people
January 01, 2017
contact@cullinanoncology.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Biological Pharmaceutical Products
Technology
Gene Technology Biotechnology
Concept
Therapeutic Products Lung Cancer
Application Scenarios
Innovative Drugs